Related Experiment Video
Updated: Apr 14, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy
Xiaoping Peng1, Xiaopeng Shen2, Xuanying Chen1
1The First Affiliated Hospital of Nanchang University, Nanchang 330006, China; Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.
Abstract:
Myotonic dystrophy is a neuromuscular disease of RNA toxicity. The disease gene DMPK harbors expanded CTG trinucleotide repeats on its 3'-UTR. The transcripts of this mutant DMPK led to misregulation of RNA-binding proteins including MBNL1 and Celf1. In myoblasts, CUG-expansion impaired terminal differentiation. In this study, we formally tested how the abundance of Celf1 regulates normal myocyte differentiation, and how Celf1 expression level mediates CUG-expansion RNA toxicity-triggered impairment of myocyte differentiation. As the results, overexpression of Celf1 largely recapitulated the defects of myocytes with CUG-expansion, by increasing myocyte cycling. Knockdown of endogenous Celf1 level led to precocious myotube formation, supporting a negative connection between Celf1 abundance and myocyte terminal differentiation. Finally, knockdown of Celf1 in myocyte with CUG-expansion led to partial rescue, by promoting cell cycle exit. Our results suggest that Celf1 plays a distinctive and negative role in terminal myocyte differentiation, which partially contribute to DM1 RNA toxicity. Targeting Celf1 may be a valid strategy in correcting DM1 muscle phenotypes, especially for congenital cases.
Insights
Celf1 negatively regulates muscle cell differentiation and contributes to myotonic dystrophy type 1 (DM1) RNA toxicity. Targeting Celf1 may offer therapeutic benefits for DM1 muscle phenotypes, particularly congenital cases.
Area of Science:
- Molecular Biology
- Genetics
- Neuromuscular Disorders
Background:
- Myotonic dystrophy type 1 (DM1) is a neuromuscular disease caused by expanded CTG trinucleotide repeats in the DMPK gene.
- These repeats lead to toxic transcripts that disrupt RNA-binding proteins, including MBNL1 and Celf1.
- CUG-expansion in myoblasts impairs terminal differentiation, a key process in muscle development.
Purpose of the Study:
- To investigate the role of Celf1 abundance in normal myocyte differentiation.
- To determine how Celf1 levels mediate the impairment of myocyte differentiation caused by CUG-expansion RNA toxicity.
- To explore Celf1 as a potential therapeutic target for DM1.
Main Methods:
- Overexpression of Celf1 in myoblasts to observe effects on differentiation.
- Knockdown of endogenous Celf1 in normal and CUG-expansion myoblasts.
- Assessment of myocyte cycling, terminal differentiation, and myotube formation.
Main Results:
- Celf1 overexpression mimicked CUG-expansion defects by increasing myocyte cycling.
- Reduced Celf1 levels promoted precocious myotube formation, indicating a negative regulatory role.
- Celf1 knockdown partially rescued CUG-expansion-induced differentiation impairment by promoting cell cycle exit.
Conclusions:
- Celf1 plays a critical, negative role in terminal myocyte differentiation.
- Celf1 contributes to the RNA toxicity observed in DM1.
- Targeting Celf1 presents a potential therapeutic strategy for DM1 muscle phenotypes, especially in congenital forms.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System
Inhibition of Cdk Activity
Positive Regulator Molecules

